Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
Srcキナーゼ阻害剤AZD0530、および、抗エストロゲン剤またはEGFR-TK-阻害剤を含む組み合わせ製品
Document Type and Number:
Japanese Patent JP2008501006
Kind Code:
A
Abstract:
The invention relates to a combination for use in the synergistic treatment of breast cancer comprising an antioestrogen and the Src kinase inhibitor AZD0530, a combination for the synergistic treatment of cancer comprising an EGFR TKI and the Src kinase inhibitor AZD0530 and a triple combination for the synergistic treatment of breast cancer comprising an antioestrogen, an EGFR TKI and the Src kinase inhibitor AZD0530.

Inventors:
Green, tim paul
Application Number:
JP2007514102A
Publication Date:
January 17, 2008
Filing Date:
May 26, 2005
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
AstraZeneca Activrag
International Classes:
A61K45/06; A61K31/517; A61P35/00; A61P43/00
Domestic Patent References:
JP2003535859A2003-12-02
Attorney, Agent or Firm:
Kazuo Shamoto
Shinjiro Ono
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Ken Matsumoto